CannaQ

Evidence-based knowledge for a healthier tomorrow

CannaQ reads the research on medical cannabis and cannabinoids, grades how strong it is, and explains it in plain English.

CannaQ logo: Science, Health, Innovation

From the blog

Every article is built from sources we can name and checked by a person before it goes live. The first articles are in preparation.

  • In preparation

    Pioneers of cannabinoid science: Raphael Mechoulam

    A sourced timeline of the discoveries that shaped the field, and what they do and don’t tell us about treatment.

  • Planned

    How to read a clinical trial

    What sample size, control groups and blinding tell you, and what a headline leaves out.

  • Planned

    THC and CBD are not the same thing

    Two cannabinoids with different effects and different risks.

How we grade evidence

Not all research is equal. Select a level to see what it can and can’t show.

What we follow

We track new studies, clinical trials and safety findings in these areas.

  • Chronic pain
  • Epilepsy
  • Multiple sclerosis
  • Spinal cord injuries
  • Sleep disorders
  • Inflammation
  • Rheumatoid arthritis
  • Anxiety and mental health
  • PTSD
  • Autism spectrum disorder
  • ADHD
  • Cancer-related symptoms
  • Palliative care
  • Drug interactions
  • Long-term safety

A topic on this list does not mean a proven cannabis treatment exists.

Independent by design

CannaQ’s content is never shaped by funding. Every article is checked against its sources and approved by a person before it is published, and we correct mistakes openly. We do not promote cannabis products or sales.

If CannaQ ever receives funding or enters a partnership, we will list it on this page and label it clearly. As of today, CannaQ has no sponsors or partners.